Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Okuda, Hiroaki ^a,b   Kuwahara, Ryusuke ^a   Matsuzaki, Shinsuke ^a,c   Miyata, Shingo ^a   Kumamoto, Natsuko ^a   Hattori, Tsuyoshi ^a   Shimizu, Shoko ^a   Yamada, Kohei ^a   Kawamoto, Keisuke ^a   Hashimoto, Ryota ^a,d   Takeda, Masatoshi ^d   Katayama, Taiichi ^c   Tohyama, Masaya ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT BINDING FACTOR; DYSBINDIN; MARCKS PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF YB; UNCLASSIFIED DRUG; CARRIER PROTEIN; DTNBP1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE; NFYB PROTEIN, MOUSE; PRIMER DNA; SIGNAL PEPTIDE;

ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EMBRYO; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN CELL; HYBRID; IMMUNOPRECIPITATION; KNOCKOUT GENE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SCHIZOPHRENIA; SCREENING; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE; YEAST; ANIMAL; CELL NUCLEUS; CYTOPLASM; GENETIC TRANSCRIPTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TUMOR CELL LINE;

MUS;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CCAAT-BINDING FACTOR; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; TRANSCRIPTION, GENETIC;

EID: 77649286765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008773     Document Type: Article

References (64)

1. Garver DL (2006) Evolution of antipsychotic intervention in the schizophrenic psychosis. Curr Drug Targets 7(9): 1205-1215.
2. Lewis DA, Gonzalez-Burgos G (2006) Pathophysiologically based treatment interventions in schizophrenia. Nat Med 12(9): 1016-1022.
3. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52(1): 139-153.
4. Mouri A, Noda Y, Enomoto T, Nabeshima T (2007) Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int 51(2-4): 173-184.
5. CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) investigators (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223.
6. Coyle JT (2006) Glutamate and schizophrenia: Beyond the dopamine hypothesis. Cell Mol Neurobiol 26(4-6): 365-384.
7. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8(6): 413-26.
8. Li B, Woo RS, Mei L, Malinow R (2007) The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54(4): 583-97.
9. Moghaddam B (2003) Bringing order to the glutamate chaos in schizophrenia. Neuron 40: 881-884.
10. Snyder SH (2006) Dopamine receptor excess and mouse madness. Neuron 49: 484-485.
11. Stephan KE, Baldeweg T, Friston KJ (2006) Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 59(10): 929-39.
12. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, et al. (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71: 337-348.
13. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, et al. (2003) Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72: 185-190.
14. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71: 877-892.
15. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, et al. (2003) Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 72: 83-87.
16. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98: 6917-6922.
17. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, et al. (2002) Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52: 701-707.
18. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, et al. (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296-1302.
19. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, et al. (2002) Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11: 1373-1380.
20. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, et al. (2004) Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 55: 192-195.
21. Chen X, Dunham C, Kendler S, Wang X, O'Neill FA, et al. (2004) Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet 129: 23-26.
22. Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, et al. (2004) Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 125: 50-53.
23. Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, et al. (1995) Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 10: 41-46.
24. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, et al. (1995) A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 11: 287-293.
25. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ (2001) Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276: 24232-24241.
26. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, et al. (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113(9): 1353-1363.
27. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, et al. (2004) Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 61(6): 544-55.
28. Chiba S, Hashimoto R, Hattori S, Yohda M, Lipska B, et al. (2006) Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J Neural Transm 113(9): 1337-46.
29. Bray NJ, Preece A, Williams NM, Moskvina V, Buckland PR, et al. (2005) Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 14: 1947-1954.
30. Corvin A, Donohoe G, Nangle JM, Schwaiger S, Morris D, et al. (2008) A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Neurosci Lett 431(2): 146-149.
31. Donohoe G, Morris DW, Clarke S, McGhee KA, Schwaiger S, et al. (2007) Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia 45(2): 454-458.
32. Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, et al. (2006) Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet 15(10): 1563-8.
33. Luciano M, Miyajima F, Lind PA, Bates TC, Horan M, et al. (2008) Variation in the dysbindin gene and normal cognitive function in three independent population samples. Genes Brain Behav.
34. Zinkstok JR, de Wilde O, van Amelsvoort TA, Tanck MW, Baas F, et al. (2007) Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behav Brain Funct 3: 19.
35. Sillitoe RV, Benson MA, Blake DJ, Hawkes R (2003) Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. J Neurosci 23(16): 6576-85.
36. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, et al. (2004) Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 13: 2699-2708.
37. Murotani T, Ishizuka T, Hattori S, Hashimoto R, Matsuzaki S, et al. (2007) High dopamine turnover in the brains of Sandy mice. Neurosci Lett 421(1): 47-51.
38. Hattori S, Murotani T, Matsuzaki S, Ishizuka T, Kumamoto N, et al. (2008) Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem Biophys Res Commun 373(2): 298-302.
39. Kumamoto N, Matsuzaki S, Inoue K, Hattori T, Shimizu S, et al. (2006) Hyperactivation of Midbrain Dopaminergic System in Schizophrenia could be attributed to the Down-regulation of Dysbindin. Biochem Biophys Res Commun 345(2): 904-905.
40. Kubota K, Kumamoto N, Matsuzaki S, Hashimoto R, Hattori T, et al. (2009) Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization. Biochem Biophys Res Commun 379: 191-195.
41. Donati G, Imbriano C, Mantovani R (2006) Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters. Nucleic Acids Res 34(10): 3116-27.
42. Gurtner A, Manni I, Fuschi P, Mantovani R, Guadagni F, et al. (2003) Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation. Mol Biol Cell 14(7): 2706-15.
43. Li Q, Herrler M, Landsberger N, Kaludov N, Ogryzko VV, et al. (1998) Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo. EMBO J 17(21): 6300-15.
44. Maity SN, de Crombrugghe B (1998) Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem Sci 23(5): 174-8.
45. Nian H, Fan C, Liao S, Shi Y, Zhang K, et al. (2007) RNF151, a testis-specific RING finger protein, interacts with dysbindin. Arch Biochem Biophys 465(1): 157-163.
46. Trifaró J, Rosé SD, Lejen T, Elzagallaai A (2000) Two pathways control chromaffin cell cortical F-actin dynamics during exocytosis. Biochimie 82(4): 339-352.
47. Sasaki Y (2003) New aspects of neurotransmitter release and exocytosis: Rhokinase-dependent myristoylated alanine-rich C-kinase substrate phosphorylation and regulation of neurofilament structure in neuronal cells. J Pharmacol Sci 93(1): 35-40.
48. Park YS, Hur EM, Choi BH, Kwak E, Jun DJ, et al. (2006) Involvement of protein kinase C-epsilon in activity-dependent potentiation of large dense-core vesicle exocytosis in chromaffin cells. J Neurosci 26(35): 8999-9005.
49. Maejima T, Oka S, Hashimotodani Y, Ohno-Shosaku T, Aiba A, et al. (2005) Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J Neurosci 25(29): 6826-35.
50. Koh TW, Bellen HJ (2003) Synaptotagmin I, a Ca2+ sensor for neurotransmitter release. Trends Neurosci 26(8): 413-22.
51. Manji HK, Lenox RH (1999) Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46(10): 1328-51.
52. Sokolov BP, Tcherepanov AA, Haroutunian V, Davis KL (2000) Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol Psychiatry 48(3): 184-96.
53. van den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, et al. (2003) The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 73: 1438-1443.
54. Tang JX, Zhou J, Fan JB, Li XW, Shi YY, et al. (2003) Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 8: 717-718.
55. van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, et al. (2003) Identification of a high-risk haplotype for the dystrobrevin binding protein 1(DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry 8: 499-510.
56. Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, et al. (2004) Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiat 61: 336-344.
57. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, et al. (2004) Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 75: 891-898.
58. Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, et al. (2004) Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 55: 971-975.
59. Fanous AH, van den Oord EJ, Riley BP, Aggen SH, Neale MC, et al. (2005) Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 162: 1824-1832.
60. Gornick MC, Addington AM, Sporn A, Gogtay N, Greenstein D, et al. (2005) Dysbindin (DTNBP1, 6p22.3) is Associated with Childhood-Onset Psychosis and Endophenotypes Measured by the Premorbid Adjustment Scale (PAS). J Autism Dev Disord 10: 1-8.
61. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, et al. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9: 1415-1423.
62. Millar JK, Christie S, Anderson S, Lawson D, Hsiao-Wei LD, et al. (2001) Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry 6: 173-178.
63. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, et al. (2003) Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 8: 685-694.
64. Hattori T, Baba K, Matsuzaki S, Honda A, Miyoshi K, et al. (2007) A novel DISC1-interacting partner DISC1-Binding Zincfinger protein: implication in the modulation of DISC1-dependent neurite outgrowth. Mol Psychiatry 12: 398-407.